Nucleic Acid Sequencing
AssigneeQiagen GmbH
InventorFrank Larsen
Life of this patent
Estimating the term…
Loading patent…
AssigneeQiagen GmbH
InventorFrank Larsen
Estimating the term…
A method for determining a target nucleic acid sequence, wherein the target nucleic acid sequence is comprised in a preparation comprising a non-target nucleic acid sequence, the target nucleic acid sequence and the non-target nucleic acid sequence each having a first region of common sequence upstream of a first region of dissimilar sequence upstream of a second region of dissimilar sequence, the method comprising: (a) contacting the preparation with an oligonucleotide primer complementary to at least a portion of the first region of common sequence, under conditions to hybridise the primer thereto; and (b) subjecting the preparation to a sequencing reaction, such that the sequencing reaction proceeds into the second region of dissimilar sequence of the target nucleic acid sequence, thereby determining at least the second region of dissimilar sequence of the target nucleic acid sequence; and wherein the method further comprises a step of blocking the sequencing reaction between the primer and the non-target nucleic acid sequence, such that the sequencing reaction does not proceed into the second region of dissimilar sequence of the non-target nucleic acid sequence.
A method for determining a target nucleic acid sequence, the method comprising the steps of:
A method for determining a plurality of target nucleic acid sequences which method comprises the steps of:
A method of pyrosequencing a sample of DNA from a subject for determining the haplotype of the subject comprising the steps of:
A kit for determining one or more target nucleic acid sequences, wherein the one or more target nucleic acid sequences are comprised in a preparation comprising one or more target nucleic acid sequences, one or more non-target nucleic acid sequences, the one or more target nucleic acid sequences and the one or more non-target nucleic acid sequences each having a first region of common sequence upstream of a first region of dissimilar sequence upstream of a second region of dissimilar sequence, comprising one or more oligonucleotide primers complementary to at least a portion of the first region of common sequence and one or more terminator nucleotides.
Dependencies are inferred from the claim text.